Compare ALEMBIC with NEULAND LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs NEULAND LABS - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC NEULAND LABS ALEMBIC/
NEULAND LABS
 
P/E (TTM) x 59.5 46.7 127.3% View Chart
P/BV x 5.1 3.5 145.1% View Chart
Dividend Yield % 0.2 0.1 194.5%  

Financials

 ALEMBIC   NEULAND LABS
EQUITY SHARE DATA
    ALEMBIC
Mar-18
NEULAND LABS
Mar-20
ALEMBIC/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs72754 9.6%   
Low Rs34247 13.7%   
Sales per share (Unadj.) Rs4.7594.5 0.8%  
Earnings per share (Unadj.) Rs6.112.6 48.3%  
Cash flow per share (Unadj.) Rs6.237.0 16.9%  
Dividends per share (Unadj.) Rs0.202.00 10.0%  
Dividend yield (eoy) %0.40.4 94.5%  
Book value per share (Unadj.) Rs40.7553.4 7.3%  
Shares outstanding (eoy) m267.0312.83 2,081.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.30.8 1,338.1%   
Avg P/E ratio x8.739.6 21.9%  
P/CF ratio (eoy) x8.513.5 62.7%  
Price / Book Value ratio x1.30.9 144.0%  
Dividend payout %3.315.8 20.7%   
Avg Mkt Cap Rs m14,1396,421 220.2%   
No. of employees `000NA1.3 0.0%   
Total wages/salary Rs m2071,236 16.8%   
Avg. sales/employee Rs ThNM5,949.4-  
Avg. wages/employee Rs ThNM963.8-  
Avg. net profit/employee Rs ThNM126.4-  
INCOME DATA
Net Sales Rs m1,2557,627 16.5%  
Other income Rs m37039 952.9%   
Total revenues Rs m1,6257,666 21.2%   
Gross profit Rs m1111,019 10.9%  
Depreciation Rs m38313 12.1%   
Interest Rs m2216 0.8%   
Profit before tax Rs m442529 83.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24367 6.5%   
Profit after tax Rs m1,630162 1,005.6%  
Gross profit margin %8.913.4 66.3%  
Effective tax rate %5.469.4 7.8%   
Net profit margin %129.82.1 6,110.3%  
BALANCE SHEET DATA
Current assets Rs m1,8675,152 36.2%   
Current liabilities Rs m5913,576 16.5%   
Net working cap to sales %101.620.7 492.1%  
Current ratio x3.21.4 219.2%  
Inventory Days Days94105 89.7%  
Debtors Days Days7491 80.9%  
Net fixed assets Rs m1,7913,969 45.1%   
Share capital Rs m534129 414.0%   
"Free" reserves Rs m10,3246,971 148.1%   
Net worth Rs m10,8587,100 152.9%   
Long term debt Rs m41774 5.3%   
Total assets Rs m11,59112,310 94.2%  
Interest coverage x260.93.5 7,555.1%   
Debt to equity ratio x00.1 3.5%  
Sales to assets ratio x0.10.6 17.5%   
Return on assets %14.13.1 458.6%  
Return on equity %15.02.3 657.5%  
Return on capital %15.29.5 160.5%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m195,187 0.4%   
Fx outflow Rs m2641,593 16.6%   
Net fx Rs m-2443,594 -6.8%   
CASH FLOW
From Operations Rs m236573 41.1%  
From Investments Rs m-224-487 46.0%  
From Financial Activity Rs m-27-55 48.5%  
Net Cashflow Rs m-1533 -45.4%  

Share Holding

Indian Promoters % 64.0 36.3 176.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 63.7 0.3%  
FIIs % 9.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 63.7 41.0%  
Shareholders   54,701 12,705 430.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   ELDER PHARMA  FDC  SHASUN PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  

Compare ALEMBIC With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views on News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Mar 5, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS